Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

被引：0
|
作者：
Samuel Seidu
Setor K. Kunutsor
Howard D. Sesso
J. M. Gaziano
J. E. Buring
Maria Carla Roncaglioni
Kamlesh Khunti
机构：
[1] Leicester Diabetes Centre,Diabetes Research Centre
[2] Leicester General Hospital,National Institute for Health Research Bristol Biomedical Research Centre
[3] University of Leicester,Translational Health Sciences, Bristol Medical School, Musculoskeletal Research Unit
[4] Leicester General Hospital,Division of Preventive Medicine
[5] University Hospitals Bristol NHS Foundation Trust and University of Bristol,Department of Medicine, Division of Aging
[6] University of Bristol,undefined
[7] Brigham and Women’s Hospital,undefined
[8] Brigham and Women’s Hospital,undefined
[9] Istituto di Ricerche Farmacologiche Mario Negri-IRCCS,undefined
来源：
Cardiovascular Diabetology | / 18卷
关键词：
Aspirin; Diabetes; Primary prevention; Cardiovascular disease; All-cause mortality; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] An approach to exploring patterns of imbalance and potential missingness in reports of the randomized baseline values for primary outcomes measurable at baseline in randomized controlled trials for meta-analyses
    Park, Eun-Gee
    Hahn, Seokyung
    BMC MEDICAL RESEARCH METHODOLOGY, 2022, 22 (01)
  • [22] An approach to exploring patterns of imbalance and potential missingness in reports of the randomized baseline values for primary outcomes measurable at baseline in randomized controlled trials for meta-analyses
    Eun-Gee Park
    Seokyung Hahn
    BMC Medical Research Methodology, 22
  • [23] Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials
    Swart, Karin M. A.
    Lips, Paul
    Brouwer, Ingeborg A.
    Jorde, Rolf
    Heymans, Martijn W.
    Grimnes, Guri
    Gruebler, Martin R.
    Gaksch, Martin
    Tomaschitz, Andreas
    Pilz, Stefan
    Eiriksdottir, Gudny
    Gudnason, Vilmundur
    Wamberg, Louise
    Rejnmark, Lars
    Sempos, Christopher T.
    Durazo-Arvizu, Ramon A.
    Dowling, Kirsten G.
    Hull, George
    Skrabakova, Zuzana
    Kiely, Mairead
    Cashman, Kevin D.
    van Schoor, Natasja M.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2018, 107 (06): : 1043 - 1053
  • [24] Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
    Joseph, Philip
    Roshandel, Gholamreza
    Gao, Peggy
    Pais, Prem
    Lonn, Eva
    Xavier, Denis
    Avezum, Alvaro
    Zhu, Jun
    Liu, Lisheng
    Sliwa, Karen
    Gamra, Habib
    Bangdiwala, Shrikant I.
    Teo, Koon
    Diaz, Rafael
    Dans, Antonio
    Lopez-Jaramillo, Patricio
    Prabhakaran, Dorairaj
    Castellano, Jose Maria
    Fuster, Valentin
    Rodgers, Anthony
    Huffman, Mark D.
    Bosch, Jackie
    Dagenais, Gilles R.
    Malekzadeh, Reza
    Yusuf, Salim
    LANCET, 2021, 398 (10306): : 1133 - 1146
  • [25] Effects of exogenous melatonin supplementation on health outcomes: An umbrella review of meta-analyses based on randomized controlled trials
    Lim, Soojin
    Park, Seoyeon
    Koyanagi, Ai
    Yang, Jae Won
    Jacob, Louis
    Yon, Dong Keon
    Lee, Seung Won
    Kim, Min Seo
    Shin, Jae Il
    Smith, Lee
    PHARMACOLOGICAL RESEARCH, 2022, 176
  • [26] Aspirin for the primary prevention of cardiovascular events in women and men - A sex-specific meta-analysis of randomized controlled trials
    Berger, JS
    Roncaglioni, MC
    Avanzini, F
    Pangrazzi, I
    Tognoni, G
    Brown, DL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (03): : 306 - 313
  • [27] Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials
    Mahmoud, Ahmed N.
    Gad, Mohamed M.
    Elgendy, Akram Y.
    Elgendy, Islam Y.
    Bavry, Anthony A.
    EUROPEAN HEART JOURNAL, 2019, 40 (07) : 607 - 617
  • [28] SGLT2 inhibitors for prevention of primary and secondary cardiovascular outcomes: A meta-analysis of randomized controlled trials
    He, Guijun
    Yang, Guosu
    Huang, Xiaoyu
    Luo, Duan
    Tang, Chao
    Zhang, Zhen
    HEART & LUNG, 2023, 59 : 109 - 116
  • [29] Understanding treatment-subgroup effect in primary and secondary prevention of cardiovascular disease: An exploration using meta-analyses of individual patient data
    Roldan, Victor D. Torres
    Ponce, Oscar J.
    Urtecho, Meritxell
    Torres, Gabriel F.
    Belluzzo, Tereza
    Montori, Victor
    Liu, Carolina
    Barrera, Francisco
    Diaz, Alejandro
    Prokop, Larry
    Guyatt, Gordon
    Montori, Victor M.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2021, 139 : 160 - 166
  • [30] The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials
    Salem, Linda
    Saleh, Nadine
    Youssov, Katia
    Olivier, Audrey
    Charles, Perrine
    Scherer, Clarisse
    Verny, Christophe
    Bachoud-Levi, Anne-Catherine
    Maison, Patrick
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 (06) : 700 - 710
12345